Rachelle Suzanne Jacques Uni Qure N.V. (QURE) insider trading activity

Rachelle Suzanne Jacques is Director of uniQure N.V.. Currently has a direct ownership of 22,488 shares of QURE, which is worth approximately $128,181. The most recent transaction as insider was on Jun 19, 2024, when has been sold 8,080 shares (Ordinary Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 22.5K

0% 3M change

35.23% 12M change

Total Value Held $128,181

Rachelle Suzanne Jacques Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 19 2024	BUY Grant, award, or other acquisition	-	8,080 Added 26.43%	22,488 Ordinary Shares
Jun 13 2024	SELL Open market or private sale	$11,415 $5.14 p/Share	2,221 Reduced 13.36%	14,408 Ordinary Shares
Jun 16 2023	SELL Open market or private sale	$43,166 $18.76 p/Share	2,301 Reduced 12.16%	16,629 Ordinary Shares
Jun 13 2023	BUY Grant, award, or other acquisition	-	8,700 Added 31.49%	18,930 Ordinary Shares
Feb 27 2023	SELL Open market or private sale	$7,687 $20.02 p/Share	384 Reduced 3.62%	10,230 Ordinary Shares
Jun 15 2022	BUY Grant, award, or other acquisition	-	9,080 Added 46.11%	10,614 Ordinary Shares
Feb 24 2022	BUY Grant, award, or other acquisition	-	1,534 Added 50.0%	1,534 Ordinary Shares

Also insider at

AKTX

Akari Therapeutics Plc Healthcare

Chief Executive Officer

CRBP

Corbus Pharmaceuticals Holdings, Inc. Healthcare

VIE

Viela Bio, Inc.

Director

RSJ